Out-of Pocket Payments With Lymphedema in France
- Conditions
- Primary Lymphedema Secondary Lymphedema
- Registration Number
- NCT02988505
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
Lymphedema is a frequent and chronic condition posing a high burden on patients. Clinical guidelines emphasize the role of compression therapy by prescription medical devices. Even in a mandatory publicly funded health insurance system, out-of-pocket payments (OOPP) may exist due to the price and reimbursement setting processes. OOPP may threaten the equity of care and drive patients to forgo care. Our aim was to analyze the distributive effects of OOPP for lymphedema patients in France.
A prospective, multicenter study will be conducted in France in 2014 on patients with lymphedema. Household ability to pay will be specified by net income and OOPP will be assessed prospectively over 6 months for outpatient care (visits, drugs, medical devices, nursing care, biological tests, imaging, physiotherapy and transportations). Both mandatory and voluntary health insurance reimbursements will be considered. We will combine concentration curves and concentration indices to assess the distributive effects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 260
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The mean monthly out-of-pocket payment as assessed by an online self-questionnaire 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Departement information Medicale CHU Montpellier
🇫🇷Montpellier, France